Cognitive impairment in diabetes mellitus: an exploratory study


  • Sameer Chaudhary Department of Medicine, Dr. Panjabrao Deshmukh Memorial Medical College, Amravati, Maharashtra, India



Cognitive function, Brain, Diabetes, MMSE


Background: Present study was conducted to estimate the prevalence and evaluate predictors of cognitive function impairment in patients with type 2 diabetes mellitus.

Methods: This prevalence study was conducted over one year at a tertiary care teaching hospital in central India. Known cases of type 2 diabetes mellitus of more than one year of duration of illness were considered eligible. Patients with past history of head injury, seizure episode, stroke, chronic kidney disease, those taking antidepressant/antipsychotic treatment and those with pre-existing dementia were excluded. Mini-mental state examination was employed for estimation of the cognitive function. Clinical history, examination and biochemical findings were also evaluated.

Results: In all, total 332 patients with mean age of 61.33±11.33 years were studied. Two hundred patients (60.24%) were below 60 years, and 132 patients (39.76%) were over 60 years of age. Two hundred sixteen patients (65.06%) were males, and 116 (34.96%) were females. The mean duration of diabetes mellitus (DM) was 10.17±4.81 years. The mean MMSE score was 22.69±5.26 and 81 (24.4%) patients were observed to have cognitive impairment. The difference in cognitive function between those below 60 years and above 60 years was statistically significant (p=0.0214). Duration of illness was also a significant factor (p=0.0394). But gender was not observed to affect the cognitive function significantly (p=0.2497).

Conclusions: Cognitive impairment is common amongst diabetics and is directly related to age and duration of diabetes amongst them; while gender does not influence the cognitive function amongst diabetics.

Author Biography

Sameer Chaudhary, Department of Medicine, Dr. Panjabrao Deshmukh Memorial Medical College, Amravati, Maharashtra, India

Associate Professor, Department of Medicine, Dr. Panjabrao Deshmukh Memorial Medical College, Amravati


Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Available at: diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf. Accessed on 20 November 2021.

Saeedi P, Salpea P, Karuranga S, Petersohn I, Malanda B, Gregg EW, et al. Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas. Diab Res Clin Pract. 2020;162:108086.

Zhou B, Lu Y, Hajifathalian K, Bentham J, Di Cesare M, Danaei G, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4• 4 million participants. Lancet. 2016;387(10027):1513-30.

Basit A, Fawwad A, Qureshi H, Shera AS. Prevalence of diabetes, pre-diabetes and associated risk factors: second National diabetes survey of pakistan (NDSP), 2016-2017. BMJ. 2018;8(8): e020961.

Chan JC, Lim LL, Wareham NJ, Shaw JE, Orchard TJ, Zhang P, et al. Commission on diabetes: using data to transform diabetes care and patient lives. Lancet. 2020;396(10267):2019-82.

Pan A, Lucas M, Sun Q, van Dam RM, Franco OH, Manson JE, et al. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Int Med. 2010;170(21):1884-91.

Pasquier F. Diabetes and cognitive impairment: how to evaluate the cognitive status?. Diab Metab. 2010;36:S100-5.

Paul KC, Jerrett M, Ritz B. Type 2 diabetes mellitus and Alzheimer’s disease: overlapping biologic mechanisms and environmental risk factors. Curr Environ Health Rep. 2018;5(1):44-58.

Umegaki H. Type 2 diabetes as a risk factor for cognitive impairment: current insights. Clin Interven Aging. 2014;9:1011.

You Y, Liu Z, Chen Y, Xu Y, Qin J, Guo S, et al. The prevalence of mild cognitive impairment in type 2 diabetes mellitus patients: a systematic review and meta-analysis. Acta Diabetol. 2021; 58(6):671-85.

Middleton LE, Yaffe K. Promising strategies for the prevention of dementia. Arch Neurol. 2009;66(10): 1210-5.

Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diab Endocrinol. 2014;2(10):819-29.

Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exper Neuropsychol. 2004;26(8):1044-80.

Saczynski JS, Jónsdóttir MK, Garcia ME, Jonsson PV, Peila R, Eiriksdottir G, et al. Cognitive impairment: an increasingly important complication of type 2 diabetes: the age, gene/environment susceptibility–Reykjavik study. Am J Epidemiol. 2008;168(10):1132-9.

Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-98.

Kant R, Yadav P, Barnwal S, Dhiman V, Abraham B, Gawande K. Prevalence and predictors of depression in type 2 diabetes mellitus. J Edu Health Promot. 2021;10:23-9.

Allen KV, Frier BM, Strachan MW. The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol. 2004; 490(1-3):169-75.

Ryan CM, Freed MI, Rood JA, Cobitz AR, Waterhouse BR, Strachan MW. Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diab Care. 2006; 29(2):345-51.

Bruce DG, Casey GP, Grange V, Clarnette RC, Almeida OP, Foster JK, Ives FJ, Davis TM. Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle Cognition in Diabetes Study. Diabetes research and clinical practice. 2003 Jul 1;61(1):59-67.

Zilliox LA, Chadrasekaran K, Kwan JY, Russell JW. Diabetes and cognitive impairment. Curr Diab Rep. 2016;16(9):1-1.

Ho SC, Woo J, Sham A, Chan SG, Yu AL. A 3-year follow-up study of social, lifestyle and health predictors of cognitive impairment in a Chinese older cohort. Int J Epidemiol. 2001;30(6):1389-96.

Irvine K, Laws KR, Gale TM, Kondel TK. Greater cognitive deterioration in women than men with Alzheimer's disease: a meta analysis. J Clin Exper Neuropsychol. 2012;34(9):989-98.

Yu ES, Liu WT, Levy P, Zhang MY, Katzman R, Lung CT, et al. Cognitive impairment among elderly adults in Shanghai, China. J Gerontol. 1989; 44(3):S97-106.

Elias PK, Elias MF, D'Agostino RB, Cupples LA, Wilson PW, Silbershatz H, et al. NIDDM and blood pressure as risk factors for poor cognitive performance: the Framingham Study. Diab Care. 1997;20(9):1388-95.

Gottesman RF, Rawlings AM, Sharrett AR, Albert M, Alonso A, Bandeen-Roche K, et al. Impact of differential attrition on the association of education with cognitive change over 20 years of follow-up: the ARIC neurocognitive study. Am J Epidemiol. 2014;179(8):956-66.

Abbott MA, Wells DG, Fallon JR. The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses. J Neurosci. 1999;19(17):7300-8.






Original Research Articles